Vasectomy
No-Scalpel Vasectomy, Post-Vasectomy Semen Analysis, Regret & the Health-Myth Record
Evidence grade 5 of 5, Settled. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Surgical procedure (not FDA-regulated as a device/drug); endorsed by AUA Vasectomy Guideline (2012, amended 2015)
Reference only. Not medical advice.
What can go wrong
Common: short-term scrotal pain, swelling, bruising, hematoma. Chronic scrotal pain (post-vasectomy pain syndrome) affects a minority - often cited around 1-2 percent troublesome enough to seek treatment. Early failure (recanalization) and rare late failure mean contraception is not reliable until a PVSA confirms azoospermia or rare nonmotile sperm. Vasectomy does NOT protect against STIs. It should be considered permanent; reversal is not guaranteed.
This is something to take to a clinician. The Atlas can tell you what is known about vasectomy in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Vasectomy occludes the vas deferens to block sperm from entering the ejaculate. The no-scalpel technique (Li Shunqiang, China, 1974) uses a sharpened forceps puncture rather than an incision, cutting hematoma and infection rates. It is a 10-20 minute office procedure under local anesthesia, far safer and cheaper than female tubal ligation, with a failure rate around 1 in 2,000 after a confirmed clear post-vasectomy semen analysis. Decades of large cohorts have debunked the feared links to prostate cancer and cardiovascular disease.
The most reliable form of contraception a man can buy - and the most maligned by myth.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
The vas deferens carrying sperm from each epididymis is isolated, divided, and occluded - typically by a combination of cautery of the lumen plus fascial interposition (placing a tissue layer between the cut ends), which the AUA found yields the lowest failure rates. Sperm production in the testis continues unchanged; sperm are simply reabsorbed. Testosterone, ejaculate volume, erections, and orgasm are unaffected because sperm make up under 5 percent of semen volume - the rest is seminal vesicle and prostate fluid.
What people get wrong
Often saidVasectomy lowers testosterone or causes ED
ActuallyIt does not. Testosterone is made in the testis and enters the bloodstream directly; the vas only carries sperm. Hormones, libido, erections, and ejaculate volume are essentially unchanged.
Often saidVasectomy causes prostate cancer
ActuallyThe early 1990s scare was not confirmed. After a brief 2014 signal for lethal disease, large cohorts including a 2017 JAMA Internal Medicine study found no clinically meaningful causal association; detection bias likely explained earlier signals.
Often saidYou are sterile right away
ActuallyNo. Residual sperm persist downstream for weeks. Sterility is confirmed only by a post-vasectomy semen analysis, typically at 8-16 weeks; unprotected sex before clearance causes pregnancies.
Often saidVasectomy is easily reversible
ActuallyIt should be regarded as permanent. Reversal is possible but costly, often not insurance-covered, and success falls as the obstructive interval lengthens.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
How we got here
Vasectomy was performed in the late 19th and early 20th centuries - tragically including in coercive eugenic sterilization programs in the US and elsewhere before becoming a voluntary contraceptive choice. The no-scalpel technique was developed by Dr. Li Shunqiang in China in 1974 and popularized internationally by the 1980s-90s, dramatically reducing complications and broadening uptake.
- 1974Li Shunqiang develops no-scalpel vasectomy in China
- 1980s-90sNo-scalpel technique spreads internationally; complication rates fall
- 1993Two studies raise a prostate-cancer concern, later not substantiated
- 2012AUA publishes its evidence-based Vasectomy Guideline
- 2017Large JAMA Internal Medicine cohort finds no meaningful prostate-cancer link
- 2022US clinics report surges in vasectomy inquiries after Dobbs
The people taking it
Most common in men in their 30s-40s who have completed childbearing. Uptake varies widely by country and culture; it is high in some high-income nations and low where female sterilization predominates. US clinics and several reports described a spike in vasectomy consultations following the 2022 Dobbs decision.
What we do not know
- What is the true incidence and best treatment of post-vasectomy pain syndrome?
- How much of the post-Dobbs vasectomy surge will persist versus reflect a temporary spike?
- Can occlusion technique be further optimized to push failure rates even lower?
The market for this
What follows describes how this is bought and sold. It is not a buying guide and it is not an endorsement of any seller.
Often a few hundred to ~1,000 USD, frequently covered by insurance; far cheaper than tubal ligation or long-term contraception over time. The post-vasectomy semen analysis is an additional small cost.
At a glance
- Duration
- ~10-20 min, local anesthesia
- Failure rate
- ~1 in 2,000 after clearance (vs ~1 in 200 tubal ligation)
- No-scalpel origin
- Li Shunqiang, China, 1974
- Sterility timing
- NOT immediate - requires PVSA confirmation (~3 months)
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Vasectomy. A short entry is not a safe entry.
- Supply chain. We have not mapped where it is made.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
AUA Vasectomy Guideline2012 (amended 2015)
Established no-scalpel/minimally invasive isolation and occlusion with mucosal cautery plus fascial interposition as best practice; PVSA at 8-16 weeks
Health Professionals Follow-Up Study, prostate cancer2014 (Siddiqui et al., JCO)
Reported a small association with lethal prostate cancer - later large analyses and a 2017 JAMA Internal Medicine cohort (Jacobs et al.) found no meaningful causal link
Schwingl & Guess review of vasectomy safety2000
Pooled data showed no credible link to cardiovascular disease, testicular cancer, or immune disease